Back

A comparative study of LCZ696, valsartan and resveratrol for the treatment of acute cardiac remodeling and dysfunction in myocardial infarction induced rats

28 May 2018 (10:18 - 10:24)
Organised by:
Congress Presentation Part of: Moderated Poster session 4 - Basic Science Treatment HFA Premium Access Heart Failure 2018

About the speaker

Photo
Mr Pema Raj

University of Manitoba, Manitoba (Canada)

9 More presentations in this session

Presentation thumbnail
Alpha1-adrenergic receptor agonists activate Akt signalling via insulin family receptors
Doctor D. Meijles (London, GB)
Abstract
Presentation thumbnail
Kruppel-like factors regulation in a zebrafish heart failure model
Mr A. Lumley (Luxembourg, LU)
Abstract
Presentation thumbnail
Improved diastolic stiffness through restored endothelial function and titin phosphorylation with chronic stimulation of soluble guanylyl cyclase in heart failure with preserved ejection fraction
Doctor A. Kovacs (Debrecen, HU)
Abstract
Presentation thumbnail
Omecamtive mecarbil causes alternating excitation-contraction coupling at high pacing frequencies
Doctor B. Horvath (Debrecen, HU)
Abstract
Presentation thumbnail
Colchicine improves experimental murine Coxsackievirus B3-induced myocarditis involving the NLRP3 inflammasome
Doctor S. Van Linthout (Berlin, DE)
Abstract

Access the full session

Session thumbnail
Moderated Poster session 4 - Basic Science

The Event

Event poster

Heart Failure 2018

28 May 2018 10:18 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Acute heart failure: what to watch for

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources